Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more likely ...
Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more likely to die of myocarditis, and myocarditis-specific fatality was more common in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results